Cargando…

Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry

BACKGROUND: Human breast cancer is classified by gene expression profile into subtypes consisting of two hormone (oestrogen and/or progesterone) receptor-positive types (luminal-like A and luminal-like B) and three hormone receptor-negative types [human epidermal growth factor receptor 2-expressing,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sassi, Francesco, Benazzi, Cinzia, Castellani, Gastone, Sarli, Giuseppe
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837647/
https://www.ncbi.nlm.nih.gov/pubmed/20109214
http://dx.doi.org/10.1186/1746-6148-6-5
_version_ 1782178838032154624
author Sassi, Francesco
Benazzi, Cinzia
Castellani, Gastone
Sarli, Giuseppe
author_facet Sassi, Francesco
Benazzi, Cinzia
Castellani, Gastone
Sarli, Giuseppe
author_sort Sassi, Francesco
collection PubMed
description BACKGROUND: Human breast cancer is classified by gene expression profile into subtypes consisting of two hormone (oestrogen and/or progesterone) receptor-positive types (luminal-like A and luminal-like B) and three hormone receptor-negative types [human epidermal growth factor receptor 2-expressing, basal-like, and unclassified ("normal-like")]. Immunohistochemical surrogate panels are also proposed to potentially identify the molecular-based groups. The present study aimed to apply an immunohistochemical panel (anti-ER, -PR, -ERB-B2, -CK 5/6 and -CK14) in a series of canine malignant mammary tumours to verify the molecular-based classification, its correlation with invasion and grade, and its use as a prognostic aid in veterinary practice. RESULTS: Thirty-five tumours with luminal pattern (ER+ and PR+) were subgrouped into 13 A type and 22 B type, if ERB-B2 positive or negative. Most luminal-like A and basal-like tumours were grade 1 carcinomas, while the percentage of luminal B tumours was higher in grades 2 and 3 (Pearson Chi-square P = 0.009). No difference in the percentage of molecular subtypes was found between simple and complex/mixed carcinomas (Pearson Chi-square P = 0.47). No significant results were obtained by survival analysis, even if basal-like tumours had a more favourable prognosis than luminal-like lesions. CONCLUSION: The panel of antibodies identified only three tumour groups (luminal-like A and B, and basal-like) in the dog. Even though canine mammary tumours may be a model of human breast cancer, the existence of the same carcinoma molecular subtypes in women awaits confirmation. Canine mammary carcinomas show high molecular heterogeneity, which would benefit from a classification based on molecular differences. Stage and grade showed independent associations with survival in the multivariate regression, while molecular subtype grouping and histological type did not show associations. This suggests that caution should be used when applying this classification to the dog, in which invasion and grade supply the most important prognostic information.
format Text
id pubmed-2837647
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28376472010-03-13 Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry Sassi, Francesco Benazzi, Cinzia Castellani, Gastone Sarli, Giuseppe BMC Vet Res Research article BACKGROUND: Human breast cancer is classified by gene expression profile into subtypes consisting of two hormone (oestrogen and/or progesterone) receptor-positive types (luminal-like A and luminal-like B) and three hormone receptor-negative types [human epidermal growth factor receptor 2-expressing, basal-like, and unclassified ("normal-like")]. Immunohistochemical surrogate panels are also proposed to potentially identify the molecular-based groups. The present study aimed to apply an immunohistochemical panel (anti-ER, -PR, -ERB-B2, -CK 5/6 and -CK14) in a series of canine malignant mammary tumours to verify the molecular-based classification, its correlation with invasion and grade, and its use as a prognostic aid in veterinary practice. RESULTS: Thirty-five tumours with luminal pattern (ER+ and PR+) were subgrouped into 13 A type and 22 B type, if ERB-B2 positive or negative. Most luminal-like A and basal-like tumours were grade 1 carcinomas, while the percentage of luminal B tumours was higher in grades 2 and 3 (Pearson Chi-square P = 0.009). No difference in the percentage of molecular subtypes was found between simple and complex/mixed carcinomas (Pearson Chi-square P = 0.47). No significant results were obtained by survival analysis, even if basal-like tumours had a more favourable prognosis than luminal-like lesions. CONCLUSION: The panel of antibodies identified only three tumour groups (luminal-like A and B, and basal-like) in the dog. Even though canine mammary tumours may be a model of human breast cancer, the existence of the same carcinoma molecular subtypes in women awaits confirmation. Canine mammary carcinomas show high molecular heterogeneity, which would benefit from a classification based on molecular differences. Stage and grade showed independent associations with survival in the multivariate regression, while molecular subtype grouping and histological type did not show associations. This suggests that caution should be used when applying this classification to the dog, in which invasion and grade supply the most important prognostic information. BioMed Central 2010-01-28 /pmc/articles/PMC2837647/ /pubmed/20109214 http://dx.doi.org/10.1186/1746-6148-6-5 Text en Copyright ©2010 Sassi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Sassi, Francesco
Benazzi, Cinzia
Castellani, Gastone
Sarli, Giuseppe
Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry
title Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry
title_full Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry
title_fullStr Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry
title_full_unstemmed Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry
title_short Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry
title_sort molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837647/
https://www.ncbi.nlm.nih.gov/pubmed/20109214
http://dx.doi.org/10.1186/1746-6148-6-5
work_keys_str_mv AT sassifrancesco molecularbasedtumoursubtypesofcaninemammarycarcinomasassessedbyimmunohistochemistry
AT benazzicinzia molecularbasedtumoursubtypesofcaninemammarycarcinomasassessedbyimmunohistochemistry
AT castellanigastone molecularbasedtumoursubtypesofcaninemammarycarcinomasassessedbyimmunohistochemistry
AT sarligiuseppe molecularbasedtumoursubtypesofcaninemammarycarcinomasassessedbyimmunohistochemistry